Immune Status During Albendazole Therapy for Hydatidosis

Overview

Journal Ann Trop Med Parasitol

Specialties Parasitology
Tropical Medicine

Date 1992 Feb 1

PMID 1616397

Citations 4

Authors

R M MATOSSIAN

G N Awar

H Radwan

P S Craig

G A Meshefedjian

Affiliations

Soon will be listed here.

Abstract

Immunological monitoring of cystic hydatid patients undergoing medico-surgical management has revealed that it is possible to assess individual host responses throughout therapy and subsequently be guided by the results obtained. The analysis has involved the demonstration of variation in haemagglutination antibodies, specific IgG and IgM immunoglobulins and circulating immune complexes before, during, and months after albendazole therapy.

Citing Articles

Immunology and immunodiagnosis of cystic echinococcosis: an update.

Zhang W, Wen H, Li J, Lin R, McManus D Clin Dev Immunol. 2012; 2012:101895.

PMID: 22235225 PMC: 3253442. DOI: 10.1155/2012/101895.

Human cystic echinococcosis: old problems and new perspectives.

Siracusano A, Teggi A, Ortona E Interdiscip Perspect Infect Dis. 2009; 2009:474368.

PMID: 19888428 PMC: 2771156. DOI: 10.1155/2009/474368.

Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates.

Rigano R, Ioppolo S, Ortona E, Margutti P, Profumo E, Ali M Clin Exp Immunol. 2002; 129(3):485-92.

PMID: 12197890 PMC: 1906476. DOI: 10.1046/j.1365-2249.2002.01925.x.

Diagnosis and treatment of human hydatidosis.

Wen H, New R, Craig P Br J Clin Pharmacol. 1993; 35(6):565-74.

PMID: 8329280 PMC: 1381596. DOI: 10.1111/j.1365-2125.1993.tb04182.x.